TALPHERA, INC. Deferred Revenue Recognized
TALPHERA, INC. (TLPH) reported Deferred Revenue Recognized of $2.57 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-10.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2022-03-10
- TALPHERA, INC. contract with customer, liability, revenue recognized for the quarter ending 2019-09-30 was $78.00K, a 13.33% decline year-over-year.
- TALPHERA, INC. contract with customer, liability, revenue recognized for the quarter ending 2019-06-30 was $79.00K, a 13.19% decline year-over-year.
- TALPHERA, INC. contract with customer, liability, revenue recognized for the quarter ending 2019-03-31 was $79.00K, a 13.19% decline year-over-year.
- TALPHERA, INC. contract with customer, liability, revenue recognized for the quarter ending 2018-09-30 was $90.00K.
- TALPHERA, INC. contract with customer, liability, revenue recognized for fiscal 2020 was $2.57M.
- TALPHERA, INC. contract with customer, liability, revenue recognized for fiscal 2018 was $362.00K.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2020-12-31 | $2.57M 10-K · filed 2022-03-10 | |||
| 2019-09-30 | $78.00K 10-Q · filed 2019-11-07 | $236.00K 10-Q · filed 2019-11-07 | ||
| 2019-06-30 | $79.00K 10-Q · filed 2019-08-06 | $158.00K 10-Q · filed 2019-08-06 | ||
| 2019-03-31 | $79.00K 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | $362.00K 10-K · filed 2019-03-07 | |||
| 2018-09-30 | $90.00K 10-Q · filed 2018-11-05 | $272.00K 10-Q · filed 2018-11-05 | ||
| 2018-06-30 | $91.00K 10-Q · filed 2018-08-02 | $182.00K 10-Q · filed 2018-08-02 | ||
| 2018-03-31 | $91.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |